Shine signs Czech license agreement

By staff writers

May 16, 2019 -- Medical isotope firm Shine Medical Technologies has signed an intellectual property license agreement with the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences (IOCB Prague).

Under terms of the deal, Shine will have exclusive license to a method for separating rare earth elements. The company plans to use the method to produce lutetium-177 (Lu-177) for cancer treatment at its new facility in Janesville, WI.

Copyright © 2019

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking